ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Osteoporosis and rheumatoid arthritis (RA)"

  • Abstract Number: 1996 • 2012 ACR/ARHP Annual Meeting

    Are Changes in Bone Mineral Density Different Between Groups of Early Rheumatoid Arthritis Patients Treated According to a Tight Control Strategy with or without Prednisone, If Osteoporosis Prophylaxis Is Applied?

    Marlies C. van der Goes1, Johannes W.G. Jacobs1, Maud S. Jurgens1, Marije F. Bakker1, Maaike J. van der Veen2, Jacobine H. van der Werf3, Paco M.J. Welsing1 and Johannes W.J. Bijlsma1, 1Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 2Rheumatology, St. Jansdal hospital, Harderwijk, Netherlands, 3Rheumatology, Diakonessenhuis, Utrecht, Netherlands

    Background/Purpose: To describe effects on bone mineral density (BMD) of treatment according to EULAR guidelines with a methotrexate-based tight control strategy including 10 mg prednisone…
  • Abstract Number: 1972 • 2012 ACR/ARHP Annual Meeting

    Assessment of Fracture Risk in Postmenopausal Women with Rheumatoid Arthritis

    Sina Esmaeilzadeh, Nurten Eskiyurt, Ekin Sen and Merih Akpinar, Physical Medicine and Rehabilitation, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey

    Background/Purpose: The aim of this study is to determine the risk of osteoporotic fracture in postmenopausal women with rheumatoid arthritis (RA) and to examine the…
  • Abstract Number: 1957 • 2012 ACR/ARHP Annual Meeting

    Prevalence and Associated Factors of Vitamin D Insufficiency and Deficiency in 4,793 Japanese Patients with Rheumatoid Arthritis

    Takefumi Furuya1, Takayuki Hosoi2, Eiichi Tanaka3, Ayako Nakajima4, Atsuo Taniguchi5, Shigeki Momohara1 and Hisashi Yamanaka1, 1Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 2Department of Clinical Research and Development, National Center for Geriatrics and Gerontology, Aichi, Japan, 3Tokyo Women's Medical University, Tokyo, Japan, 4Rheumatology, Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan, 5Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan

    Background/Purpose: Vitamin D (25[OH]D) insufficiency and deficiency is reported to be common in patients with rheumatoid arthritis (RA) and is associated with increased disease activity…
  • Abstract Number: 1258 • 2012 ACR/ARHP Annual Meeting

    Association Between Low Vitamin D Levels and Indicators of Osteoporosis and Atherosclerosis

    Barry J. Sheane1, Ruth Dunne2, Ken Scott3, Mary Hall4, Michelle O'Connor2, Martin Healy5, John Feely4, J.B. Walsh6 and Gaye Cunnane7, 1Dept. of Rheumatology, St. James's Hospital, Dublin, Ireland, 2Diagnostic Imaging Department, St James's Hospital, Dublin, Ireland, 3Department of Pharmacology and Therapeutics, Trinity College Dublin, Dublin 8, Ireland, 4Department of Pharmacology and Therapeutics, St James's Hospital, Dublin, Ireland, 5Central Pathology Laboratory, St James's Hospital, Dublin, Ireland, 6Medicine for the Elderly, St James's Hospital, Dublin, Ireland, 7Dept of Rheumatology, St James's Hospital, Dublin, Ireland

    Background/Purpose: Osteoporosis and cardiovascular disease are complications of chronic rheumatoid arthritis (RA). It is not known if these processes share pathogenetic mechanisms. Low levels of…
  • Abstract Number: 1259 • 2012 ACR/ARHP Annual Meeting

    Association Between Subclinical Atherosclerosis and Bone Mineral Density in Rheumatoid Arthritis

    Barry J. Sheane1, Ruth Dunne2, Ken Scott3, Mary Hall4, Michelle O'Connor2, Martin Healy5, John Feely4, J.B. Walsh6 and Gaye Cunnane7, 1Rheumatology, St. James Hospital, Dublin, Ireland, 2Diagnostic Imaging Department, St James's Hospital, Dublin 8, Ireland, 3Department of Pharmacology and Therapeutics, Trinity College Dublin, Dublin 8, Ireland, 4Department of Pharmacology and Therapeutics, St James's Hospital, Dublin 8, Ireland, 5Central Pathology Laboratory, Dublin 8, Ireland, 6Medicine for the Elderly, Dublin 8, Ireland, 7Dept of Rheumatology, St James's Hospital, Dublin, Ireland

    Background/Purpose: Rheumatoid arthritis (RA) is associated with a higher risk of osteoporosis (OP) and cardiovascular disease (CVD). This cross-sectional study was undertaken to identify links…
  • Abstract Number: 1226 • 2012 ACR/ARHP Annual Meeting

    Transition Time to Osteoporosis in Patients with Rheumatoid Arthritis

    Jiwon Hwang1, Joong Kyong Ahn2, Ji Young Chai3, Hoon-Suk Cha1, Jaejoon Lee1 and Eunmi Koh1, 1Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, 2Department of Medicine, Kangbuk Samsung hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea, 3Division of Rheumatology, Jesang Hospital, Seongnam-si Gyeonggi-do, South Korea

    Background/Purpose: Rheumatoid arthritis (RA) is an independent risk factor for osteoporosis. Although bone mineral density (BMD) testing is routinely performed in patients with RA, the…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology